Wisconsin Senate Bill SB1013

Wisconsin 2025-2026 Regular Session

• Introduced: 2/12/26
• Refer: 2/12/26
• Failed: 3/23/26

Caption

An Act to create 118.07 (1c) and 165.88 (3n) of the statutes; Relating to: maintaining a supply of usable opioid antagonist at a public or private school and making an appropriation. (FE)

Impact

If passed, SB1013 would amend existing state laws concerning the provision of emergency medication in schools. The requirement for schools to stock opioid antagonists not only reflects the growing recognition of the opioid crisis but also places a responsibility on educational institutions to act proactively in safeguarding the health of their students. This would likely lead to increased training for school personnel on how to administer these life-saving treatments effectively.

Summary

SB1013 aims to maintain a supply of usable opioid antagonists at both public and private schools, alongside making an appropriation for its implementation. The bill responds to the increasing concern over opioid overdoses and the need for educational institutions to have access to lifesaving medications. By ensuring that schools have the necessary resources, the bill supports the broader public health initiatives aimed at reducing fatalities and improving the safety of students and staff in the face of potential opioid-related incidents.

Contention

While many support SB1013 for its public health benefits, there are points of contention surrounding the bill, particularly concerning funding, training, and liability issues. Critics argue that the appropriation for schools may not be sufficient to cover the ongoing costs associated with procurement, training, and ensuring that the medication remains up-to-date. Additionally, concerns about whether school staff will be adequately trained to administer naloxone or other opioid antagonists may lead to discussions about liability and medical oversight, raising questions on how best to integrate this requirement into existing school health policies.